1. Brentuximab Vedotin Combined With Chemotherapy in Patients With Newly Diagnosed Early-Stage, Unfavorable-Risk Hodgkin Lymphoma. Issue 20 (10th July 2021) Authors: Kumar, Anita; Casulo, Carla; Advani, Ranjana H.; Budde, Elizabeth; Barr, Paul M.; Batlevi, Connie L.; Caron, Philip; Constine, Louis S.; Dandapani, Savita V.; Drill, Esther; Drullinsky, Pamela; Friedberg, Jonathan W.; Grieve, Clare; Hamilton, Audrey; Hamlin, Paul A.; Hoppe, Richard T.; Horwitz, S... Journal: Journal of clinical oncology Issue: Volume 39:Issue 20(2021) Page Start: 2257 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma. Issue 28 (1st October 2021) Authors: Moskowitz, Alison J.; Shah, Gunjan; Schöder, Heiko; Ganesan, Nivetha; Drill, Esther; Hancock, Helen; Davey, Theresa; Perez, Leslie; Ryu, Sunyoung; Sohail, Samia; Santarosa, Alayna; Galasso, Natasha; Neuman, Rachel; Liotta, Brielle; Blouin, William; Kumar, Anita; Lahoud, Oscar; Batlevi, Connie L.;... Journal: Journal of clinical oncology Issue: Volume 39:Issue 28(2021) Page Start: 3109 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Successful implementation of outpatient R ± DHAX (rituximab, dexamethasone, oxaliplatin, cytarabine) for select patients with lymphoma: a single-center experience. Issue 4 (21st March 2022) Authors: Pak, Terry K.; Dixon, Brianne N.; Buege, Michael J.; Dao, Phuong H.; Leary, Megan H.; Jarrett, Joy C.; Duggan, Tara A.; Caron, Philip; Falchi, Lorenzo; Hamlin, Paul; Hamilton, Audrey; Matasar, Matthew J.; Moskowitz, Alison; Noy, Ariela; Owens, Colette N.; Von Keudell, Gottfried; Younes, Anas; Zel... Journal: Leukemia & lymphoma Issue: Volume 63:Issue 4(2022) Page Start: 876 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗